World's Best Scientists 2026 revealed!
Danila Valmori

Danila Valmori

D-Index & Metrics

Immunology

D-Index
68
Citations
14456
World Ranking
2620
National Ranking
112

Danila Valmori publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Danila Valmori sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 148 publications — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Danila Valmori D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Danila Valmori sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Danila Valmori is affiliated with the University of Nantes in France, with research contributions primarily in the fields of Medicine, Immunology and Microbiology. Their work also encompasses specific subfields such as Immunology, Epidemiology, and Hepatology.

Their research topics include:

  • Immunotherapy and Immune Responses
  • Hepatitis B Virus Studies
  • Liver physiology and pathology

Danila Valmori has published research in the venue Zenodo (CERN European Organization for Nuclear Research), with at least one recorded publication.

One recent paper authored or co-authored by Valmori is:

  • Phase I/II multicenter trial of a novel therapeutic cancer vaccine, HepaVac-101, for hepatocellular carcinoma, published in 2022 in Zenodo (CERN European Organization for Nuclear Research)

Frequent co-authors who have collaborated with Valmori include:

  • Markus Löffler
  • Stefania Gori
  • Francesco Izzo
  • Andrea Mayer-Mokler
  • Paolo A. Ascierto

Best Publications

  • BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.

    Pascal Schneider;Fabienne Mackay;Véronique Steiner;Kay Hofmann

  • High Frequencies of Naive Melan-a/Mart-1–Specific Cd8+ T Cells in a Large Proportion of Human Histocompatibility Leukocyte Antigen (Hla)-A2 Individuals

    M J Pittet;D Valmori;P R Dunbar;D E Speiser

  • Ex Vivo Staining of Metastatic Lymph Nodes by Class I Major Histocompatibility Complex Tetramers Reveals High Numbers of Antigen-experienced Tumor-specific Cytolytic T Lymphocytes

    Pedro Romero;P. Rod Dunbar;Danila Valmori;Mikaël Pittet

  • Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues

    Danila Valmori;Jean François Fonteneau;Concepción Marañón Lizana;Nadine Gervois

  • Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.

    Danila Valmori;Naira E. Souleimanian;Valeria Tosello;Nina Bhardwaj

  • Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor RORγt

    Maha Ayyoub;Florence Deknuydt;Isabelle Raimbaud;Christelle Dousset

  • Cutting Edge: Cytolytic Effector Function in Human Circulating CD8+ T Cells Closely Correlates with CD56 Surface Expression

    Mikaël J. Pittet;Daniel E. Speiser;Danila Valmori;Jean-Charles Cerottini

  • A peripheral circulating compartment of natural naive CD4+ Tregs

    Unknown

  • Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.

    Elke Jäger;Julia Karbach;Sacha Gnjatic;Antje Neumann

  • Naturally Occurring Human Lymphocyte Antigen-A2 Restricted CD8+ T-Cell Response to the Cancer Testis Antigen NY-ESO-1 in Melanoma Patients

    Danila Valmori;Valérie Dutoit;Danielle Liénard;Donata Rimoldi

  • In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.

    D E Speiser;M J Pittet;D Valmori;R Dunbar

  • Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.

    Pedro Romero;Danila Valmori;Mikael J. Pittet;Alfred Zippelius

  • Heterogeneous T-Cell Response to MAGE-A10254–262 High Avidity-specific Cytolytic T Lymphocytes Show Superior Antitumor Activity

    Valérie Dutoit;Verena Rubio-Godoy;Pierre-Yves Dietrich;Anne-Lise Quiqueres

  • Thymic selection generates a large T cell pool recognizing a self-peptide in humans.

    Alfred Zippelius;Mikaël J. Pittet;Pascal Batard;Nathalie Rufer

  • Rapamycin-Mediated Enrichment of T Cells with Regulatory Activity in Stimulated CD4+ T Cell Cultures Is Not Due to the Selective Expansion of Naturally Occurring Regulatory T Cells but to the Induction of Regulatory Functions in Conventional CD4+ T Cells

    Unknown

  • Efficacy of Levo-1-Methyl Tryptophan and Dextro-1-Methyl Tryptophan in Reversing Indoleamine-2,3-Dioxygenase–Mediated Arrest of T-Cell Proliferation in Human Epithelial Ovarian Cancer

    Feng Qian;Jeannine Villella;Paul K. Wallace;Paulette Mhawech-Fauceglia

  • CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity

    Nassima Redjimi;Caroline Raffin;Isabelle Raimbaud;Pascale Pignon

  • CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.

    D E Speiser;D Valmori;D Rimoldi;M J Pittet

  • IL-1β and IL-2 convert human Treg into TH17 cells

    Unknown

  • Application of support vector machines for T-cell epitopes prediction

    Yingdong Zhao;Clemencia Pinilla;Danila Valmori;Roland Martin

  • Human memory FOXP3+ Treg secrete IL-17 ex-vivo and constitutively express the TH17 lineage specific transcription factor ROR{gamma}t

    Maha Ayyoub;Florence Deknuydt;Isabelle Raimbaud;Christelle Dousset

  • Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.

    D Valmori;U Gileadi;C Servis;P R Dunbar

  • Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma.

    Maha Ayyoub;Stefan Stevanovic;Ugur Sahin;Philippe Guillaume

Frequent Co-Authors

Jean-Charles Cerottini
Jean-Charles Cerottini University of Lausanne
Pedro Romero
Pedro Romero University of Lausanne
Daniel E. Speiser
Daniel E. Speiser University of Lausanne
Philippe Guillaume
Philippe Guillaume University of Lausanne
Mikael J. Pittet
Mikael J. Pittet University of Geneva
Vincenzo Cerundolo
Vincenzo Cerundolo University of Oxford
Alfred Zippelius
Alfred Zippelius University Hospital of Basel
Lloyd J. Old
Lloyd J. Old Ludwig Cancer Research
Pierre-Yves Dietrich
Pierre-Yves Dietrich University of Geneva
Clemencia Pinilla
Clemencia Pinilla Florida International University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA often leads to diverse career opportunities in healthcare and research. For those interested in advancing clinical expertise, programs like an accelerated FNP program offer a fast-track to becoming a Family Nurse Practitioner, which can complement immunology knowledge in patient care settings.

As career goals evolve, many professionals pursue acute care NP certification to specialize in critical and acute patient management. This certification enhances skills that are valuable when dealing with complex immune-related conditions.

For those new to nursing, exploring options like online RN programs for non nurses in Florida can provide an accessible entry point into the field. Such programs build foundational knowledge essential for careers touching on immunology and healthcare.

Salary expectations are also a key consideration; information about how much do DNPs make highlights the financial benefits of pursuing advanced nursing degrees, helping students align their academic choices with long-term career goals. Integrating immunology expertise with these paths boosts both professional growth and impact.

Best Scientists Citing Danila Valmori

Trending Scientists

Recently Published Articles